Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Facial tumor as a presenting complaint in a patient with primary Sjögren's syndrome.

National journal of maxillofacial surgery

González-Mourelle A, Castro MP, Mahía IV, López JC, Neagu D, López-Cedrún JL.
PMID: 31205394
Natl J Maxillofac Surg. 2019 Jan-Jun;10(1):87-90. doi: 10.4103/njms.NJMS_3_18.

Sjögren's syndrome is a chronic autoimmune disorder of the exocrine glands with associated lymphocytic infiltrates of the affected glands. Dryness of the mouth and eyes results from involvement of the salivary and lacrimal glands. Up to one-half of affected...

Cite
González-Mourelle A, Castro MP, Mahía IV, et al. Facial tumor as a presenting complaint in a patient with primary Sjögren's syndrome. Natl J Maxillofac Surg. 2019;10(1):87-90doi: 10.4103/njms.NJMS_3_18.
González-Mourelle, A., Castro, M. P., Mahía, I. V., López, J. C., Neagu, D., & López-Cedrún, J. L. (2019). Facial tumor as a presenting complaint in a patient with primary Sjögren's syndrome. National journal of maxillofacial surgery, 10(1), 87-90. https://doi.org/10.4103/njms.NJMS_3_18
González-Mourelle, Alicia, et al. "Facial tumor as a presenting complaint in a patient with primary Sjögren's syndrome." National journal of maxillofacial surgery vol. 10,1 (2019): 87-90. doi: https://doi.org/10.4103/njms.NJMS_3_18
González-Mourelle A, Castro MP, Mahía IV, López JC, Neagu D, López-Cedrún JL. Facial tumor as a presenting complaint in a patient with primary Sjögren's syndrome. Natl J Maxillofac Surg. 2019 Jan-Jun;10(1):87-90. doi: 10.4103/njms.NJMS_3_18. PMID: 31205394; PMCID: PMC6563643.
Copy Download .nbib Format: NLM
Surgical management of ameloblastoma. Review of literature.

Journal of clinical and experimental dentistry

Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, Carral-Roura N, Rubín-Roger G, Penedo-Vázquez Á, Luaces-Rey R, López-Cedrún JL.
PMID: 30697397
J Clin Exp Dent. 2019 Jan 01;11(1):e70-e75. doi: 10.4317/jced.55452. eCollection 2019 Jan.

BACKGROUND: Ameloblastoma is an odontogenic tumor that represents 1% of all tumors in the oral cavity and it is clinically classified in three types. Currently, solid and multi-cystic are considered locally aggressive, with high recurrence rates with conservative treatment.MATERIAL...

Cite
Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, et al. Surgical management of ameloblastoma. Review of literature. J Clin Exp Dent. 2019;11(1):e70-e75doi: 10.4317/jced.55452.
Neagu, D., Escuder-de la Torre, O., Vázquez-Mahía, I., Carral-Roura, N., Rubín-Roger, G., Penedo-Vázquez, �. �., Luaces-Rey, R., & López-Cedrún, J. L. (2019). Surgical management of ameloblastoma. Review of literature. Journal of clinical and experimental dentistry, 11(1), e70-e75. https://doi.org/10.4317/jced.55452
Neagu, David, et al. "Surgical management of ameloblastoma. Review of literature." Journal of clinical and experimental dentistry vol. 11,1 (2019): e70-e75. doi: https://doi.org/10.4317/jced.55452
Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, Carral-Roura N, Rubín-Roger G, Penedo-Vázquez Á, Luaces-Rey R, López-Cedrún JL. Surgical management of ameloblastoma. Review of literature. J Clin Exp Dent. 2019 Jan 01;11(1):e70-e75. doi: 10.4317/jced.55452. eCollection 2019 Jan. PMID: 30697397; PMCID: PMC6343988.
Copy Download .nbib Format: NLM
Review of 793 facial fractures treated from 2001 to 2008 in a coruña university hospital: types and etiology.

Craniomaxillofacial trauma & reconstruction

Pombo M, Luaces-Rey R, Pértega S, Arenaz J, Crespo JL, García-Rozado A, Patiño B, López-Cedrún JL.
PMID: 22110818
Craniomaxillofac Trauma Reconstr. 2010 Mar;3(1):49-54. doi: 10.1055/s-0030-1249373.

The purpose of this article is to analyze the incidence, demographic distribution, type, and etiology of all facial fractures treated by the Department of Oral and Maxillofacial Surgery in A Coruña University Hospital (Spain) from 2001 to 2008. A...

Cite
Pombo M, Luaces-Rey R, Pértega S, et al. Review of 793 facial fractures treated from 2001 to 2008 in a coruña university hospital: types and etiology. Craniomaxillofac Trauma Reconstr. 2010;3(1):49-54doi: 10.1055/s-0030-1249373.
Pombo, M., Luaces-Rey, R., Pértega, S., Arenaz, J., Crespo, J. L., García-Rozado, A., Patiño, B., & López-Cedrún, J. L. (2010). Review of 793 facial fractures treated from 2001 to 2008 in a coruña university hospital: types and etiology. Craniomaxillofacial trauma & reconstruction, 3(1), 49-54. https://doi.org/10.1055/s-0030-1249373
Pombo, Maria, et al. "Review of 793 facial fractures treated from 2001 to 2008 in a coruña university hospital: types and etiology." Craniomaxillofacial trauma & reconstruction vol. 3,1 (2010): 49-54. doi: https://doi.org/10.1055/s-0030-1249373
Pombo M, Luaces-Rey R, Pértega S, Arenaz J, Crespo JL, García-Rozado A, Patiño B, López-Cedrún JL. Review of 793 facial fractures treated from 2001 to 2008 in a coruña university hospital: types and etiology. Craniomaxillofac Trauma Reconstr. 2010 Mar;3(1):49-54. doi: 10.1055/s-0030-1249373. PMID: 22110818; PMCID: PMC3052662.
Copy Download .nbib Format: NLM
Impact of the Presenting Symptom on Time Intervals and Diagnostic Routes of Patients with Symptomatic Oral Cancer.

Cancers

Varela-Centelles PI, López DP, López-Cedrún JL, García-Rozado Á, Baz PC, Romero-Méndez A, Seoane J.
PMID: 34680312
Cancers (Basel). 2021 Oct 14;13(20). doi: 10.3390/cancers13205163.

This investigation was aimed at determining the time intervals from the presenting symptoms until the beginning of oral cancer treatment and their relative contribution to the total time, and to assess the impact of the presenting symptom on diagnostic...

Cite
Varela-Centelles PI, López DP, López-Cedrún JL, et al. Impact of the Presenting Symptom on Time Intervals and Diagnostic Routes of Patients with Symptomatic Oral Cancer. Cancers (Basel). 2021;13(20)doi: 10.3390/cancers13205163.
Varela-Centelles, P. I., López, D. P., López-Cedrún, J. L., García-Rozado, �. �., Baz, P. C., Romero-Méndez, A., & Seoane, J. (2021). Impact of the Presenting Symptom on Time Intervals and Diagnostic Routes of Patients with Symptomatic Oral Cancer. Cancers, 13(20), . https://doi.org/10.3390/cancers13205163
Varela-Centelles, Pablo Ignacio, et al. "Impact of the Presenting Symptom on Time Intervals and Diagnostic Routes of Patients with Symptomatic Oral Cancer." Cancers vol. 13,20 (2021). doi: https://doi.org/10.3390/cancers13205163
Varela-Centelles PI, López DP, López-Cedrún JL, García-Rozado Á, Baz PC, Romero-Méndez A, Seoane J. Impact of the Presenting Symptom on Time Intervals and Diagnostic Routes of Patients with Symptomatic Oral Cancer. Cancers (Basel). 2021 Oct 14;13(20). doi: 10.3390/cancers13205163. PMID: 34680312; PMCID: PMC8533728.
Copy Download .nbib Format: NLM
Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer.

Journal of clinical medicine

Rapado-González Ó, López-Cedrún JL, López-López R, Rodríguez-Ces AM, Suárez-Cunqueiro MM.
PMID: 33947071
J Clin Med. 2021 Apr 29;10(9). doi: 10.3390/jcm10091931.

Oral carcinogenesis is a multistep process characterized by a summation of multiple genetic and epigenetic alterations in key regulatory genes. The silencing of genes by aberrant promoter hypermethylation is thought to be an important epigenetic event in cancer development...

Cite
Rapado-González Ó, López-Cedrún JL, López-López R, et al. Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer. J Clin Med. 2021;10(9)doi: 10.3390/jcm10091931.
Rapado-González, �. �., López-Cedrún, J. L., López-López, R., Rodríguez-Ces, A. M., & Suárez-Cunqueiro, M. M. (2021). Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer. Journal of clinical medicine, 10(9), . https://doi.org/10.3390/jcm10091931
Rapado-González, Óscar, et al. "Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer." Journal of clinical medicine vol. 10,9 (2021). doi: https://doi.org/10.3390/jcm10091931
Rapado-González Ó, López-Cedrún JL, López-López R, Rodríguez-Ces AM, Suárez-Cunqueiro MM. Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer. J Clin Med. 2021 Apr 29;10(9). doi: 10.3390/jcm10091931. PMID: 33947071; PMCID: PMC8124791.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries